Yokneam, Israel-based Rapid Medical designed the Comaneci embolization device to facilitate the treatment of cerebral vasospasm following hemorrhagic stroke.
In a news release, the company touted clinical results for the platform, which is already available in Europe for vasospasm intervention. In a 30-patient multi-center retrospective analysis, 97% of patients showed an increase in vessel opening of at least 25%, while 80% showed an increase of 50% or more.
Rapid Medical noted that more than 10,000 procedures have been performed worldwide with Comaneci assisting in the coil embolization of wide-neck intracranial aneurysms.
The company touts features such as an adjustable diameter, lowe delivery profile and strong visibility, with the temporary device offering a treatment modality that may prevent …